Jefferies Aggressively Boosts PT on ICON plc (ICLR); Positive on CRO Revenue Growth

Article Stock Quotes (4) Comments (0)

Jefferies boosted its price target on Buy-rated ICON plc (NASDAQ: ICLR) from $33.50 to $38 citing see ample untapped opportunity for CRO revenue growth over a 5-yr horizon.

The firm's proprietary survey shows that sponsors expect: "1) R&D spending to return to growth; 2) outsourcing penetration to continue to rise; 3) strategic deals to grow in importance to sponsor R&D strategies; and 4) more balanced spending across the R&D continuum"

In addition to ICON plc, the firm likes Charles River Laboratories (NYSE: CRL) and WuXi PharmaTech Inc. (NYSE: WX).

The firm also raised their price target on Hold-rated PAREXAL (NASDAQ: PRXL) from $31 to $36.

For an analyst ratings summary and ratings history on ICON plc click here. For more ratings news on ICON plc click here.

Shares of ICON plc closed at $31.74 yesterday, with a 52 week range of $20.02-$32.19.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
• Wells Fargo Starts StealthGas (GASS) at Outperform
• UPDATE: Oppenheimer Upgrades GameStop (GME) to Outperform

Create E-mail Alert Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?